4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-004569
CEO and CFO bought 1,000 shares at $18.68 ($18,680)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2023-02-10 | Purchase | +1,000 | $18.68 | $18,680 | 2,735,886 | D |
| Open-market purchases · 1,000 sh · avg $18.68 · $18,680 | |||||||
Loading xslF345X03/ownership.xml…